RxDoctor Payments Data

Marissa Steele, MD

Internal Medicine · San Diego, CANPI 1386871721

Payments from drug & device makers

$512in general payments, 2019–2025

Across 26 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$128
  • Lilly USA, LLC$100
  • AstraZeneca$71
  • Boehringer Ingelheim$49
  • Edwards Lifesciences$40
  • AbbVie$34
  • plus $91 from 6 others

What the payments were for

  • Food & beverage$512100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$512 in reported general payments places this provider in the 65th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Medicare billing

Part B allowed, 2024
$40,365
Medicare patients
229
Services billed
257

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amlodipine Besylate14$106

Paid to pharmacies, not to this prescriber.

Other internal medicine in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →